Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · 2013 · 62 citations · 28 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyOncologic Nuclear MedicineLymphoma ImagingPositron Emission TomographyTumor CharacterizationTumor Imaging18F-fluorodeoxyglucose Positron Emission TomographyHodgkin Lymphoma ImagingLymphoma StagingNon-hodgkin Lymphoma ImagingNon-hodgkin Lymphoma TreatmentPet-computed TomographyRestaging Of LymphomaTreatment Strategies
Lymphomas are a heterogeneous group of diseases that arise from the constituent cells of the immune system or from their precursors. 18F-fludeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) is now the cornerstone of staging procedures in the state-of-the-art management of Hodgkin's disease and aggressive non-Hodgkin's lymphoma. It plays an important role in staging, restaging, prognostication, planning appropriate treatment strategies, monitoring therapy, and detecting recurrence. However, its role in indolent lymphomas is still unclear and calls for further investigational trials. The protean PET/CT manifestations of lymphoma necessitate a familiarity with the spectrum of imaging findings to enable accurate diagnosis. A meticulous evaluation of PET/CT findings, an understanding of its role in the management of lymphomas, and knowledge of its limitations are mandatory for the optimal utilization of this technique.
28
Revised Response Criteria for Malignant Lymphoma
Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text
Malik E. Juweid, Sigrid Stroobants, Otto S. Hoekstra et al. · Journal of Clinical Oncology · 2007 · 1.3K citations · Full text
Medicine, Nuclear Medicine, Oncology +16
Procedure guideline for tumor imaging with F-18 FDG PET/CT
Dominique Delbeke, R. Edward Coleman, Milton J. Guiberteau et al. · 2006 · 628 citations